Malignant tumors firmly occupy a leading place in the structure of morbidity and mortality in many leading countries of the world. As the authors of literary sources note, research in the field of certain areas of combined therapy of malignant neoplasms is currently being intensively developed. The development of drugs to combat neoplasms is developing especially intensively, since drug therapy is the leading component of the combined method of treating malignant tumors.